CTLA4 and sarcoma: Similarly, combined PD-1 and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) blockade with RT cures transplant p53/MCA sarcomas (Fig. 1c), but this combined immune checkpoint blockade with RT fails to overcome resistance in the primary model (Fig. 1d).